Back to search
FDAFDA · Food and drugs·Recall number D-145-2013

Taztia XT(diltiazem HCI extended release capsules, USP, Once-A-Day Dosage, 360 mg, 90 Capsules per bottle, Rx only, Manufactured by: Watson Laboratories, Inc., Corona, CA 92880, Distributed by: Watson Pharma, NDC 62037-700-90.

Published February 13, 2013 · Recall initiated: December 18, 2012

Summary

FDA records drug Class II recall D-145-2013, published February 13, 2013 and initiated December 18, 2012. Recalling firm: Watson Pharmaceuticals; Status: Terminated; Reported quantity: 3,040 bottles; Lot: Lot #: 512146A, Exp 01/31/2014. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Dissolution Specification: Out of a specification result occurred during the 3-month stability testing. Dissolution result at the 4-hour time point was 41% (specification: 20-40%).

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Watson Pharmaceuticals
Distributor
Nationwide and Puerto Rico
Lot
Lot #: 512146A, Exp 01/31/2014
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Taztia XT(diltiazem HCI extended release capsules, USP, Once-A-Day Dosage, 360 mg, 90 Capsules per bottle, Rx only, Manufactured by: Watson Laboratories, Inc., Corona, CA 92880, Distributed by: Watson Pharma, NDC 62037-700-90. recalled?

Yes. FDA published recall D-145-2013 on February 13, 2013. Reported hazard: Failed Dissolution Specification: Out of a specification result occurred during the 3-month stability testing. Dissolution result at the 4-hour time point was 41% (specification: 20-40%).

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail